Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Category : Search result: pharma company India
ReNew Energy Invests ₹60K Crore in Andhra Pradesh
NASDAQ-listed ReNew Energy announces massive ₹60,000 crore investment in Andhra Pradesh, boosting state's renewable energy capacity and creating significant economic impact.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
RVNL Shares Fall 3% on Weak Quarterly Results
Rail Vikas Nigam shares declined 3% after reporting 20% drop in Q2 profit. Revenue grew but margins contracted. Stock down 51% from peak. Read full analysis.
HT Media Q2 Loss Narrows to ₹4.34 Crore
HT Media Ltd reduces quarterly loss to ₹4.34 crore while revenue grows to ₹451.50 crore. Print and digital segments show strong growth despite radio challenges. Read full analysis.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Hindustan Copper Q2 profit jumps 85% to ₹186 crore
State-owned Hindustan Copper reports impressive 85% surge in Q2 FY26 net profit reaching ₹186.02 crore, driven by robust income growth. Discover the key financial highlights and operational insights.
Apex Ecotech H1 FY26 Revenue Jumps 50% to ₹32.57 Cr
Apex Ecotech Limited reports stellar H1 FY26 results with 50.09% revenue growth to ₹32.57 crore. New orders boost future visibility. Read the complete financial analysis.
Fujiyama Power Systems IPO Opens Nov 13: Details
Fujiyama Power Systems launches ₹828 crore IPO from Nov 13-17. Learn about price band, financial performance, and key risks before investing in this solar energy company.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Kalyan Jewellers Q2 Profit Soars 100% to ₹260 Cr
Kalyan Jewellers reports stellar Q2 FY2024 results with net profit doubling to ₹260 crore and revenue surging 30% year-on-year. Discover how India's love for gold is driving this spectacular growth.
DESCO Infratech Strong H1 FY2025 Results
DESCO Infratech Limited announces impressive financial performance for H1 FY2025, reporting significant revenue growth and profitability while reaffirming strong projections for H2.
StarRez Picks Hyderabad for APAC SaaS Hub
Global student housing SaaS leader StarRez announces major APAC expansion in Hyderabad, creating 150+ tech jobs and establishing India as strategic innovation hub for global operations.
Mitsu Chem Plast Q2 Profit Jumps 66%
Mitsu Chem Plast Limited reports outstanding Q2 FY26 results with 66% net profit growth and 11% revenue increase, showcasing robust financial health and operational excellence.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Shreeji Global FMCG ₹85 Crore IPO Closes Nov 7
Shreeji Global FMCG Limited launches ambitious ₹85 crore IPO to fuel expansion and strengthen market position. Discover key dates, price band, and growth plans.
SBI's $100B Turnaround: From Losses to Banking Giant
Discover how State Bank of India transformed from a loss-making entity in 2018 into a $100 billion financial giant, driven by strategic regulatory reforms implemented by RBI Governor Malhotra.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Nilkamal Q2 Profit Surges 18% on B2B, E-commerce Growth
Nilkamal Ltd reports stellar Q2 FY2024 results with 18% profit growth driven by strong B2B and e-commerce performance. Revenue climbs as plastic furniture giant expands market reach.
Bombay Shirt Company Expands Across Delhi-NCR
Premium custom shirt brand Bombay Shirt Company announces major expansion across Delhi-NCR with new stores and experience centers, revolutionizing personalized fashion in North India.
Ola Electric Q2: Losses Narrow to ₹418 Cr
Ola Electric shows mixed Q2 results with narrowed losses but significant revenue decline. Analysis of financial performance, market challenges, and future outlook for India's EV giant.
India's Company Law Administration Overhaul from Jan 2024
India's corporate regulatory framework undergoes significant transformation with revamped Company Law Administration launching in January 2024, promising streamlined services and robust oversight for businesses.
Delhivery Q2: Losses Narrow to ₹50Cr, New CFO Takes Over
Delhivery shows significant financial improvement with reduced Q2 losses and strategic leadership changes as Vivek Pabari prepares to take over as CFO.
Kaynes Technology Q2 Profit Jumps 168%
Kaynes Technology reports explosive Q2 growth with net profit surging 168% to ₹59 crore and revenue climbing 86%, driven by strong semiconductor and electronics manufacturing demand.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Page 1 of 4